BioInsights - Pandemic preparedness: the vaccine manufacturer’s perspective

Pandemic preparedness: the vaccine manufacturer’s perspective

Vaccine Insights 2023; 2(5), 161–165

DOI: 10.18609/vac.2023.026

Published: 6 June
Interview
Jane True


Charlotte Barker, Editor, Vaccine Insights, speaks to Jane True, VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead, Pfizer, to get her thoughts on building pandemic preparedness and the complexities of vaccine equity.